Natural Product: NPC116377

Natural Product IDNPC116377
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2,5-Imino-2,5,6-Trideoxy-D-Manno-Heptitol
IUPAC Name (2R,3R,4R,5R)-2-(2-hydroxyethyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
Synonyms 6-deoxyhomoDMDP
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL407337
PubChem CID 10374978
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000218] Pyrrolidines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey AGFACLQFIYFFOI-DBRKOABJSA-N
Standard InCHI InChI=1S/C7H15NO4/c9-2-1-4-6(11)7(12)5(3-10)8-4/h4-12H,1-3H2/t4-,5-,6-,7-/m1/s1
SMILES C(CO)[C@@H]1[C@H]([C@@H]([C@@H](CO)N1)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   177.1 Volume:   167.23
?
Van der Waals volume.
Dense:   1.059 LogP:   -1.895
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -1.548
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   0.515
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   5.0
TPSA:   92.95
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   5.0 Rings:   1.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.326 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.147 Fsp3:   1.0
MCE-18:   18.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.04 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.034
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.116 Promiscuous compounds:   0.279

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.783 MDCK Permeability:   -4.971
Pgp-inhibitor:   0.001 Pgp-substrate:   0.847
PAMPA:   0.972
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.925
20% Bioavailability (F20%):   0.424 30% Bioavailability (F30%):   0.963
50% Bioavailability (F50%):   0.889

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.225 MRP1:   0.151
Plasma Protein Binding (PPB):   16.425% Volume Distribution (VD):   -0.397
Fu: 88.172%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.761
OATP1B3 inhibitor:   0.929 BCRP inhibitor:   0.077
BSEP inhibitor:   0.002

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.048 CYP2C9-substrate:   0.003
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.001
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.225
HLM stability:   0.027
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.13 Half-life (T1/2):  2.291

ADMET: Toxicity

hERG Blockers:  0.03 hERG Blockers (10um):  0.176
Human Hepatotoxicity (H-HT):  0.544 Drug-induced Liver Injury (DILI):  0.131
AMES Toxicity:  0.442 Rat Oral Acute Toxicity:  0.053
Maximum Recommended Daily Dose:  0.015 Skin Sensitization:  0.913
Carcinogencity:  0.253 Eye Corrosion:  0.245
Eye Irritation:  0.959 Respiratory Toxicity:  0.075
Drug-induced Neurotoxicity:  0.066 Ototoxicity:  0.781
Hematotoxicity:  0.294 Drug-induced Nephrotoxicity:  0.589
Genotoxicity:  0.021 RPMI-8226 Immunitoxicity:  0.046
A549 Cytotoxicity:  0.016 Hek293 Cytotoxicity:  0.031
BCF:   0.1
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   1.318
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   2.38
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   1.747
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33353 scilla sibirica Species Hyacinthaceae Eukaryota n.a. n.a. n.a. PMID[12502331]
NPO18491 Hyacinthus orientalis Species Hyacinthaceae Eukaryota n.a. n.a. n.a. PMID[9599261]
NPO18491 Hyacinthus orientalis Species Hyacinthaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18491 Hyacinthus orientalis Species Hyacinthaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18491 Hyacinthus orientalis Species Hyacinthaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18491 Hyacinthus orientalis Species Hyacinthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1648 Individual protein Oligo-1,6-glucosidase Saccharomyces cerevisiae S288c IC50 = 250000.0 nM PMID[24927053]
NPT1058 Individual protein Beta-glucosidase A Caldicellulosiruptor saccharolyticus IC50 = 350000.0 nM PMID[20159656]
NPT1051 Individual protein Lactase-glycosylceramidase Rattus norvegicus IC50 = 320000.0 nM PMID[19410459]
NPT509 Individual protein Beta-galactosidase Bos taurus IC50 = 88000.0 nM PMID[15620264]
NPT462 Individual protein Sucrase-isomaltase Rattus norvegicus Inhibition < 50.0 % PMID[18077363]
NPT462 Individual protein Sucrase-isomaltase Rattus norvegicus IC50 = 11000.0 nM PMID[18077363]
NPT5854 Individual protein Uncharacterized protein Sus scrofa Inhibition < 50.0 % PMID[9599261]
NPT506 Individual protein Beta-mannosidase Rattus norvegicus IC50 = 320000.0 nM PMID[3934384]
NPT514 Individual protein Glycogen debranching enzyme Homo sapiens IC50 = 11000.0 nM PMID[20303767]
NPT671 Individual protein Acidic alpha-glucosidase Rattus norvegicus Inhibition < 50.0 % PMID[23398362]
NPT496 Individual protein Alpha-L-fucosidase 1 Bos taurus Inhibition < 50.0 % PMID[17279797]
NPT671 Individual protein Acidic alpha-glucosidase Rattus norvegicus IC50 = 2500.0 nM PMID[20594858]
NPT671 Individual protein Acidic alpha-glucosidase Rattus norvegicus IC50 = 7200.0 nM PMID[17064068]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. Inhibition < 50.0 % PMID[17993275]
NPT2 Others Unspecified n.a. IC50 = 94000.0 nM PMID[15620264]
NPT2 Others Unspecified n.a. IC50 = 2200.0 nM PMID[20594858]
NPT2 Others Unspecified n.a. IC50 = 380000.0 nM PMID[12608862]
NPT2 Others Unspecified n.a. IC50 = 60000.0 nM PMID[17691763]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC116377 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC69798
0.6538 Remote Similarity NPC473710
0.5909 Remote Similarity NPC62507
0.5909 Remote Similarity NPC602743
0.5172 Remote Similarity NPC268922

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC116377 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data